Full-Time
Posted on 7/13/2025
Develops and manufactures medical devices and therapies
No salary listed
Senior, Expert
Hyderabad, Telangana, India
In Person
Medtronic provides medical technology, services, and solutions to improve patient care. The company develops a variety of medical devices, including pacemakers, insulin pumps, surgical tools, and neurostimulation devices, which help diagnose, prevent, and treat chronic diseases. Medtronic's products are used by hospitals and healthcare professionals around the world. What sets Medtronic apart from its competitors is its strong focus on research and development, allowing it to continuously innovate and expand its product offerings. The company's goal is to enhance patient outcomes and reduce healthcare costs through its comprehensive range of products and services.
Company Size
10,001+
Company Stage
IPO
Headquarters
Fridley, Minnesota
Founded
1949
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Sick Leave
Paid Holidays
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Employee Assistance Program
Wellness Program
GALWAY, Ireland, June 23, 2025 /PRNewswire(opens new window)/ - Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Board of Directors appointed Dr. Joon Lee, CEO at Emory Healthcare, Inc., to the Board as an independent director, effective June 18, 2025.
Medtronic has announced a voluntary recall of select Newport HT70 and Newport HT70 Plus ventilators and certain related service parts for the devices.
Medtronic Rebrands Diabetes Business as “MiniMed” Ahead of Spin-Off. by Jasmine Pennic 06/13/2025 Leave a Comment. What You Should Know: – Medtronic announced that its planned New Diabetes Company will be named MiniMed. The name honors the company’s roots, reflecting its original name prior to its acquisition by Medtronic in 2001 and its deep, 40-year history of transforming diabetes care worldwide.The announcement marks a significant step in the intended separation of Medtronic’s Diabetes business into a new, independent entity.Simplify Life with DiabetesThe new MiniMed’s mission is to make diabetes more predictable so that everyone can embrace life to the fullest. The company aims to address the constant mental and physical demands required to keep glucose levels in a healthy range, developing technology that helps push the daily burden of diabetes management into the background.Based in Northridge, California, the Diabetes business consists of a passionate team of more than 8,000 employees. Medtronic is targeting the completion of the planned separation within 18 months of its initial announcement, subject to customary conditions and legal requirements.“Our journey began in 1983, when visionary entrepreneur Alfred E
Medtronic expects to execute the separation through an initial public offering followed by a split-off transaction.
Ghost Productions has worked with some of the biggest names in the medical device industry, including Medtronic, Boston Scientific, and Johnson & Johnson.